Lv3
310 积分 2026-01-23 加入
Relevance of Half-Life in Drug Design
1天前
待确认
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
3天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
4天前
已完结
Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside
11天前
已完结
Engineering strategies and binding mechanisms of therapeutic anti–PD-1 antibodies approved by regulatory agencies globally
1个月前
已完结
The molecular blueprint of targeted radionuclide therapy
1个月前
已完结
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 2
2个月前
已关闭
Fibroblast Activation Protein-Targeted Theranostics: Current Status in Clinical Development
2个月前
已完结
Regulation of cell signalling by uPAR
2个月前
已完结
Senolytic CAR T cells reverse senescence-associated pathologies
2个月前
已完结
皖公网安备34019202002308
